| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |